Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis. (Q53655424)
Jump to navigation
Jump to search
scientific article published in October 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis. |
scientific article published in October 2005 |
Statements
Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis. (English)
David Miller
Paul O'Connor
Katherine Riester
Minhua Yang
Michael Panzara
Catherine Dalton
Katherine Miszkiel
Omar Khan
George Rice
William Sheremata
International Natalizumab Trial Group
1 October 2005
11
5
568-572
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference